COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,620 Articles (22,913 medRxiv, 8,707 bioRxiv)

Most recent first Previous |  Page 448: Articles 4471-4480  | Next

Reduced SARS-CoV-2 infection and altered antiviral transcriptional response in IBD intestinal organoids.
Jelusic, B., Boerno, S., Wurm, P., Przysiecki, N., Watschinger, C., Wolfgruber, S., Anthofer, M., Ehmann, S., Klages, S., Zatloukal, K., Timmermann, B., Moschen, A., Gorkiewicz, G.
10.1101/2023.06.05.23290961 — Posted: 2023-06-05
Feature Selection for an Explainability Analysis in Detection of COVID-19 Active Cases from Facebook User-Based Online Surveys
Rufino, J., Ramirez, J. M., Aguilar, J., Baquero, C., Champati, J., Frey, D., Lillo, R. E., Fernandez Anta, A.
10.1101/2023.05.26.23290608 — Posted: 2023-06-05
Impact of patient gender on low back pain management before and after the COVID-19 pandemic in commercially insured and Medicare Advantage cohorts. A retrospective cohort study
Elton, D., Zhang, M.
10.1101/2023.06.05.23290968 — Posted: 2023-06-05
POST-COVID ORTHOPAEDIC ELECTIVE RESOURCE PLANNING USING SIMULATION MODELLING
Harper, A., Monks, T., Wilson, R., Redaniel, M. T., Eyles, E., Jones, T., Penfold, C., Elliott, A., Keen, T., Pitt, M., Blom, A., Whitehouse, M., Judge, A.
10.1101/2023.05.31.23290774 — Posted: 2023-06-05
Social genomics, cognition, and well-being during the COVID-19 pandemic
Bateman, J. R., Krisnamurthy, S., Quillen, E. E., Waugh, C. E., Kershaw, K. N., Lockhart, S. N., Hughes, T. M., Seeman, T. E., Cole, S. W., Craft, S.
10.1101/2023.05.31.23290618 — Posted: 2023-06-05
A flexible and high-throughput genotyping workflow tracked the emergence of SARS-CoV-2 variants in the UK in 2022
Lee, S. Y., Grujic, S., Modern, S., Wann, A., Fraser, D. P., Percival, B. C.
10.1101/2023.06.03.23289684 — Posted: 2023-06-05
Potential involvement of protein phosphatase PP2CA on protein synthesis and cell cycle during SARS-CoV-2 infection. A meta analysis investigation
Otvos, L. P., Garrito, G. I. M., Machado, L. E. S. F.
10.1101/2023.06.02.543487 — Posted: 2023-06-05
Machine Learning-Guided Antibody Engineering That Leverages Domain Knowledge To Overcome The Small Data Problem
Clark, T., Subramanian, V., Jayaraman, A., Fitzpatrick, E., Gopal, R., Pentakota, N., Rurak, T., Anand, S., Viglione, A., Tharakaraman, K., Raman, R., Sasisekharan, R.
10.1101/2023.06.02.543458 — Posted: 2023-06-05
A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism
Yao, Y., Zhang, Y., Li, Z., Chen, Z., Wang, X., Li, Z., Yu, L., Cheng, X., Li, W., Jiang, W.-J., Wu, H.-J., Feng, Z., Sun, J., Fei, T.
10.1101/2023.06.03.543589 — Posted: 2023-06-05
A non-enzymatic test for SARS-CoV-2 RNA using DNA nanoswitches
Vilcapoma, J., Aliyeva, A., Hayden, A., Chandrasekaran, A. R., Zhou, L., Abraham Punnoose, J., Yang, D., Hansen, C., Shiu, S. C.-C., Russell, A., St. George, K., Wong, W., Halvorsen, K.
10.1101/2023.05.31.23290613 — Posted: 2023-06-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).